Cargando…

Erratum: Characteristics of Children with Bronchopulmonary Dysplasia with Prolonged and/or Later-Onset Pulmonary Hypertension

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169132/ https://www.ncbi.nlm.nih.gov/pubmed/35648082 http://dx.doi.org/10.1513/AnnalsATS.v19erratum2

Ejemplares similares

Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
por: Zhong, Ying, et al.
Publicado: (2023)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Erratum: Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental Bronchopulmonary Dysplasia
Publicado: (2023)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
por: An, Hyo Soon, et al.
Publicado: (2010)

Pulmonary Hemosiderosis in Children with Bronchopulmonary Dysplasia
por: Kurahara, David, et al.
Publicado: (2014)

Digital Subtraction Pulmonary Angiography in Children with Pulmonary Hypertension due to Bronchopulmonary Dysplasia
por: Das, Bibhuti, et al.
Publicado: (2019)

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis [Erratum]
Publicado: (2018)

Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia: A Review
por: Varghese, Nidhy, et al.
Publicado: (2019)

Pulmonary infection caused by Nocardia cyriacigeorgica in a patient with allergic bronchopulmonary aspergillosis: A case report: Erratum
Publicado: (2019)

Erratum: Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry
Publicado: (2022)

Erratum: Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry
Publicado: (2021)

Role of left atrial hypertension in pulmonary hypertension associated with bronchopulmonary dysplasia
por: Sullivan, Rachel T., et al.
Publicado: (2022)

Pulmonary Hypertension Complicating Fibrosing Mediastinitis: Erratum
Publicado: (2016)

Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis
por: van der Graaf, Marisa, et al.
Publicado: (2019)

Signaling Pathways Involved in the Development of Bronchopulmonary Dysplasia and Pulmonary Hypertension
por: Mathew, Rajamma
Publicado: (2020)

Novel Strategies to Reduce Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia
por: El-Saie, Ahmed, et al.
Publicado: (2020)

Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
por: Dillon, Kacie, et al.
Publicado: (2023)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Erratum: Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: Pulmonary hypertension due to left heart disease
Publicado: (2017)

Pulmonary Vascular Underperfusion Score in Premature Infants with Bronchopulmonary Dysplasia and Pulmonary Hypertension
por: Das, Bibhuti B., et al.
Publicado: (2019)

Children with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension Treated with Pulmonary Vasodilators—The Pediatric Cardiologist Point of View
por: Migdał, Anna, et al.
Publicado: (2021)

A prediction model of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia
por: Wang, Chenhong, et al.
Publicado: (2022)

Use of Inhaled Iloprost in an Infant With Bronchopulmonary Dysplasia and Pulmonary Artery Hypertension
por: Hwang, Seung-Kyung, et al.
Publicado: (2009)

Fetal Growth Restriction and Pulmonary Hypertension in Premature Infants with Bronchopulmonary Dysplasia
por: Check, Jennifer, et al.
Publicado: (2013)

Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future
por: Fike, Candice D., et al.
Publicado: (2023)

Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension
por: Nawaytou, Hythem, et al.
Publicado: (2023)

Erratum: Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry
Publicado: (2022)

Erratum: Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry
Publicado: (2022)

Erratum: Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates
Publicado: (2017)

Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension: Erratum
Publicado: (2023)

Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension
por: Hansmann, Georg, et al.
Publicado: (2012)

Early Detection for Right Ventricular Dysfunction in Bronchopulmonary Dysplasia without Pulmonary Hypertension
por: Son, Jung-Woo
Publicado: (2016)

Role of functional echocardiographic parameters in the diagnosis of bronchopulmonary dysplasia-associated pulmonary hypertension
por: Dasgupta, Soham, et al.
Publicado: (2021)

Association of newer definitions of bronchopulmonary dysplasia with pulmonary hypertension and long-term outcomes
por: Hwang, Jae Kyoon, et al.
Publicado: (2023)

A multidisciplinary approach to severe bronchopulmonary dysplasia is associated with resolution of pulmonary hypertension
por: Yung, Delphine, et al.
Publicado: (2023)

Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats: Erratum
Publicado: (2015)

Significant Differences in Markers of Oxidant Injury between Idiopathic and Bronchopulmonary-Dysplasia-Associated Pulmonary Hypertension in Children
por: Vera, Kimberly B., et al.
Publicado: (2012)

Erratum to the effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension
por: Huang, Zheyong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ihp8cbmb2v92nj2hg43qphkjir